Market Dynamics:
The growth of the cancer chemotherapy associated nausea and vomiting therapeutics market is attributed to increasing incidence and prevalence of cancer worldwide. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and was responsible for nearly 10 million deaths in 2020. Rising number of chemotherapy procedures performed annually is also expected to boost the demand for anti-emetic drugs. Additionally, new product launches catering to various cancer types and routes of drug administration are expected to offer lucrative growth opportunities over the forecast period. However, high costs associated with advanced therapeutics and chemotherapy procedures may restrain the market to a certain extent.

Key Takeaways:

The Global Cancer Chemotherapy Associated Nausea And Vomiting Therapeutics Market Size is expected to witness high growth, exhibiting CAGR of 5.7% over the forecast period, due to increasing prevalence of cancer globally. Advancements in cancer treatment modalities and rising numbers of older population requiring chemotherapy are expected to drive market revenues.

For More Insights, Read: https://newsinsights123.blogspot.com/2023/12/antiemetic-drugs-are-fastest-growing.html